RT Journal Article
SR Electronic
T1 Stenting versus medical treatment for idiopathic intracranial hypertension: a matched-control study
JF Journal of NeuroInterventional Surgery
JO J NeuroIntervent Surg
FD BMJ Publishing Group Ltd.
SP neurintsurg-2022-019191
DO 10.1136/jnis-2022-019191
A1 Raynald
A1 Hongchao Yang
A1 Xu Tong
A1 Xiaochuan Huo
A1 Xiaoqing Li
A1 Lian Liu
A1 Binbin Sui
A1 Hui Qu
A1 Kehui Dong
A1 Yilong Wang
A1 Shuran Wang
A1 Zhongrong Miao
A1 Dapeng Mo
YR 2022
UL http://jnis.bmj.com/content/early/2022/10/06/jnis-2022-019191.abstract
AB Background This prospective cohort study compared the outcomes of stenting and medical treatment for patients with idiopathic intracranial hypertension (IIH) and venous sinus stenosis (VSS).Methods In this single-center cohort study, patients with IIH and VSS were evaluated between January 2014 and December 2019 with follow-up periods of 1, 3, and 6 months. The patients received either stenting or medical treatment. The two groups underwent 1:1 matching using propensity score analysis, and the clinical outcomes were compared.Results Following 1:1 matching, 36 patients who underwent stenting and 36 who underwent medical treatment were matched. The median improvements in the papilledema Frisén grade were greater in the stenting group at 1 month (−2 vs 0), 3 months (−3 vs −1), and 6 months (−3 vs −1) than in the medical treatment group. Patients who received stenting treatment had a significantly higher prevalence of complete resolution of their respective symptoms (headache, tinnitus, or visual disturbances) at 3 months (58.3% vs 13.9%, OR 8.68, 95% CI 2.74 to 27.52) and 6 months (80.6% vs 22.2%, OR 14.50, 95% CI 4.64 to 45.32) than those receiving medical treatment.Conclusions This matched-control study shows that stenting has a greater efficacy rate and rapid resolution of papilledema and its respective symptoms compared with medical treatment.Data are available upon reasonable request.